Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 262

    1.

    C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance.

    Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS.

    Diabetes Care. 2003 Aug;26(8):2323-8.PMID: 12882856 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.

    Motala AA, Omar MA, Gouws E.

    Diabetes Care. 1997 Jul;20(7):1101-7.PMID: 9203444 [PubMed - indexed for MEDLINE]Related articles

    3.

    High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.

    Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G.

    Chin Med J (Engl). 2008 Dec 20;121(24):2509-16.PMID: 19187587 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.

    Viswanathan V, Clementina M, Nair BM, Satyavani K.

    J Assoc Physicians India. 2007 Dec;55:833-7.PMID: 18405128 [PubMed - indexed for MEDLINE]Related articles

    5.

    Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.

    Chou P, Li CL, Wu GS, Tsai ST.

    Diabetes Care. 1998 Jul;21(7):1183-7.PMID: 9653617 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?

    Wong MS, Gu K, Heng D, Chew SK, Chew LS, Tai ES.

    Diabetes Care. 2003 Nov;26(11):3024-30.PMID: 14578234 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of obesity on the conversion from normal glucose tolerance to diabetes in Hong Kong Chinese.

    Ko GT, Chan JC, Chow CC, Yeung VT, Chan WB, So WY, Cockram CS.

    Obes Res. 2004 Jun;12(6):889-95.PMID: 15229326 [PubMed - indexed for MEDLINE]Related articles

    9.

    Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance.

    Lam TH, Liu LJ, Janus ED, Lam KS, Hedley AJ; Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee.

    Diabet Med. 2000 Nov;17(11):798-806.PMID: 11131105 [PubMed - indexed for MEDLINE]Related articles

    10.

    Community-based epidemiological study of glucose tolerance in Kin-Chen, Kinmen: support for a new intermediate classification.

    Tsai ST, Li CL, Chen CH, Chou P.

    J Clin Epidemiol. 2000 May;53(5):505-10.PMID: 10812323 [PubMed - indexed for MEDLINE]Related articles

    11.

    Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.

    Diabetes Prevention Program Research Group.

    Diabetes Care. 2005 Oct;28(10):2472-9.PMID: 16186282 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.

    Hung YJ, Lin SH, Pei D, Kuo SW, Hsieh CH, He CT, Hsing Lee C, Fan SC, Sheu WH.

    Metabolism. 2006 Apr;55(4):439-44.PMID: 16546473 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?

    Sargeant LA, Boyne MS, Bennett FI, Forrester TE, Cooper RS, Wilks RJ.

    Rev Panam Salud Publica. 2004 Jul;16(1):35-42.PMID: 15333264 [PubMed - indexed for MEDLINE]Related articles

    15.

    Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population.

    Lin J, Zhang M, Song F, Qin J, Wang R, Yao P, Ying C, Hu FB, Liu L.

    Diabetes Metab Res Rev. 2009 Mar;25(3):219-23.PMID: 19116941 [PubMed - indexed for MEDLINE]Related articles

    16.

    Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.

    Invitti C, Gilardini L, Pontiggia B, Morabito F, Mazzilli G, Viberti G.

    Nutr Metab Cardiovasc Dis. 2006 May;16(4):256-62. Epub 2006 Jan 4.PMID: 16679217 [PubMed - indexed for MEDLINE]Related articles

    18.

    The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.

    Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R; Baltimore Longitudinal Study of Aging.

    Diabetes. 2003 Jun;52(6):1475-84.PMID: 12765960 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study]

    Henkel E, Köhler C, Temelkova-Kurktschiev T, Hanefeld M.

    Dtsch Med Wochenschr. 2002 May 3;127(18):953-7. German. PMID: 11987015 [PubMed - indexed for MEDLINE]Related articles

    20.

    Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance.

    Tankova T, Dakovska L, Kirilov G, Koev D.

    Exp Clin Endocrinol Diabetes. 2001;109(7):355-60.PMID: 11573145 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data